Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 24;26(5):637–650. doi: 10.1007/s12282-019-00970-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Pfizer Inc. 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 2 — Dose levels and treatment duration in Japanese patients with and without dose reduction within 180 days of treatment initiation. a PALOMA-2, b Japanese phase 2 study, and c PALOMA-3. FUL fulvestrant, LET letrozole, PAL palbociclib

Fig. 2 — Dose levels and treatment duration in Japanese patients with and without dose reduction within 180 days of treatment initiation. a PALOMA-2, b Japanese phase 2 study, and c PALOMA-3. FUL fulvestrant, LET letrozole, PAL palbociclib